Efficacy of Nalbuphine in Restraining Oxytocin-Induced Discomfort During Operative Delivery
DOI:
https://doi.org/10.51253/pafmj.v76i2.11171Keywords:
Anesthesia, Cesarean section, Nalbuphine, Spinal, OxytocinAbstract
Objective: To measure the intensity of pain caused by bolus of Oxytocin during cesarean delivery and efficacy of Nalbuphine to control it.
Study Design: Quasi-experimental study.
Place and Duration of Study: Department of Obstetrics and Gynecology, Combined Military Hospital Quetta, Pakistan from May to October 2023.
Methodology: This Quasi-experimental study was conducted in CMH Quetta for a duration of six months (May-October 2023). The ethical board of hospital granted permission (ERC#CMH QTA-IERB/09/2023). Total 150 patients were included in the study after application of inclusion and exclusion criteria. Patients were divided into two groups marked as: Group-S (n=75) and Group-N (n=75). The Group-S patients did not receive Nalbuphine and Group-N patients received Nalbuphine. The primary outcome was frequency of side effects in both groups and secondary outcome was patient’s satisfaction.
Results: The frequency of adverse effects in Group-S was higher than the Group-N patients. The most frequent side effect was chest pain with the frequency of 16(21.3%) in Group-S patients and 2(2.7%) in Group-N patients with p value of <0.001. The patient satisfaction was better in Group-N patients. The frequency of patient satisfaction was 72(96.0%) in Group-N patients and 47(62.7%) in Group-S patients with p-value <0.001.
Conclusion: Nalbuphine can mitigate discomfort due to Oxytocin bolus in parturient undergoing cesarean section under Centro-axial anesthesia.
Downloads
References
1. Acharya G, Al-Sammarai MT, Patel N, Al-Habib A, Kiserud T. A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section. Acta Obstetricia Gynecologica Scandinavica 2001; 80(3): 245-250.
https://doi.org/10.1034/j.1600-0412.2001.080003245.x
2. Sheehan SR, Montgomery AA, Carey M, McAuliffe FM, Eogan M, Gleeson R, Get al. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ 2011; 343: d4661. https://doi.org/10.1136/bmj.d4661
3. Zeng Y, Zhang Y, Zhen M, Lao L, Ma Y, Liu L, et al. Side-effects of oxytocin in postpartum hemorrhage: a systematic review and meta-analysis. Am J Transl Res 2022; 14(3): 1934-1951.
4. Arias F. Pharmacology of oxytocin and prostaglandins. Clin Obstet Gynecol 2000; 43(3): 455-468.
https://doi.org/10.1097/00003081-200009000-00006
5. Rosseland L A, Hauge T H, Grindheim G, Stubhaug A, Langesæter E; Changes in Blood Pressure and Cardiac Output during Cesarean Delivery: The Effects of Oxytocin and Carbetocin Compared with Placebo. Anesthesiology 2013; 119: 541–551. https://doi.org/10.1097/aln.0b013e31829416dd
6. Kashif A, Kiani RB, Shabbir SM, Mahmood T, Sabir G, Fatima N et al. Epigastric pain after intravenous administration of oxytocin in patients undergoing lower segment cesarean section: A quasi experimental study comparing intravenous bolus with infusion technique. Anaesth Pain Intensive Care 2020; 24(1): 50-53. https://doi.org/10.35975/apic.v24i1.1225
7. Nakić Radoš S, Tadinac M, Herman R. Anxiety During Pregnancy and Postpartum: Course, Predictors and Comorbidity with Postpartum Depression. Acta Clin Croat 2018; 57(1): 39-51. https://doi.org/10.20471/acc.2017.56.04.05
8. Chen Y, Yang X, Guo C, Liao Y, Guo L, Chen W, et al. Prevalence of post-traumatic stress disorder following caesarean section: a systematic review and meta-analysis. J Womens Health 2020; 29(2): 200-209.
https://doi.org/10.1089/jwh.2019.7750
9. Waseem A, Aslam P, Kazmi IH, Qaisar SE. Compare the frequency of epigastric pain after intravenous infusion versus intravenous bolus administration of oxytocin in C-section. Pak J Med Sci 2021; 5(3): 558-559.
10. Kashif A, Kiani RB, Shabbir SM, Mahmood T, Sabir G, Fatima et al. Epigastric pain after intravenous administration of oxytocin in patients undergoing lower segment cesarean section: A quasi experimental study comparing intravenous bolus with infusion technique. Anaesth Pain Intensive Care 2020; 24(1): 50-53.
https://doi.org/10.35975/apic.v24i1.1225
11. Ayad AE, Salman OH, Ibrahim AM, Al-Taher WA, Mishriky AM, Pergolizzi JV et al. Influences of gender on intravenous nalbuphine actions after major abdominal surgery: a multicenter study. Pain Ther 2021; 10(2): 1215-1233.
https://doi.org/10.1007/s40122-021-00277-6
12. Craig D, Carli F. Bromage motor blockade score – a score that has lasted more than a lifetime. Can J Anesth 2018; 65(7): 837–838. https://doi.org/10.1007/s12630-018-1101-7
13. Habib AS. A review of the impact of phenylephrine administration on maternal hemodynamics and maternal and neonatal outcomes in women undergoing cesarean delivery under spinal anesthesia. Anesth Analg 2012; 114(2): 377-390.
https://doi.org/10.1213/ane.0b013e3182373a3e
14. Krywko DM, King KC. Aortocaval compression syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021
15. Chen Y, Liu W, Gong X, Cheng Q. Comparison of Effects of General Anesthesia and Combined Spinal/Epidural Anesthesia for Cesarean Delivery on Umbilical Cord Blood Gas Values: A Double-Blind, Randomized, Controlled Study. Med Sci Monit 2019; 25: 5272-5279. https://doi.org/10.12659/MSM.914160
16. Sane S, Hasanlui MV, Abbasivash R, Mahoori A, Hashemi ST, Rafiei F. Comparing the effect of intravenous dexamethasone, intravenous ondansetron, and their combination on nausea and vomiting in cesarean section with spinal anesthesia. Adv Biomed Res 2015; 4: 230.
https://doi.org/10.4103/2277-9175.167030
17. Bhiwal AK, Chauhan K, Choudhary S, Bhatt HA, Gupta S. Intravenous ondansetron to prevent hypotension during cesarean section under spinal anaesthesia. Int J Obstet Anesth Crit Care 2021; 11(1): 15-19.
https://doi.org/10.4103/joacc.joacc_61_20
18. Langesaeter E, Rosseland LA, Stubhaug A. Hemodynamic effects of oxytocin during cesarean delivery. Int J Obstet Anesth 2006; 95(1): 46-47. https://doi.org/10.1016/j.ijgo.2006.05.032
19. Bolton TJ, Randall K, Yentis SM. Effect of the Confidential Enquiries into Maternal Deaths on the use of Syntocinon® at caesarean section in the UK. Anaesthesia 2003; 58(3): 277-279. https://doi.org/10.1046/j.1365-2044.2003.30435.x
20. Mishra PK, Yadav JBS, Singh AK, Singh RB. Comparison of Intravenous Nalbuphine and Paracetamol on Maternal Hemodynamic Status, Neonatal APGAR Score, and Postoperative Pain given before Induction of General Anesthesia for Elective Cesarean Section. Anesth Essays Res 2020; 14(2): 219-225. https://doi.org/10.4103/aer.aer_69_20
21. Schoppmann S, Spiess D, Müller D, Burch A, Zimmermann R, Simões-Wüst AP. Nalbuphine: a candidate for treatment of women overwhelmed with sudden, intense labor pain? J Matern Fetal Neonatal Med 2022; 35(25): 6112-6114.
https://doi.org/10.1080/14767058.2021.1906859
22. Tammisto T, Tigerstedt I. Comparison of the analgesic effects of intravenous nalbuphine and pentazocine in patients with postoperative pain. Acta Anaesthesiologica Scandinavica 1977; 21(5): 390-394.
https://doi.org/10.1111/j.1399-6576.1977.tb01237.x
23. Larsen D, Maani CV. Nalbuphine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Munnaza Andleeb, Ayisha Raja, Fatima Sharif , Kaukab Majeed, Kaswar Sajjad Ansari , Syeda Surayya Jabeen

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





